+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vital Signs Monitoring Devices Market by Product type and End User - Global Opportunity Analysis and Industry Forecast, 2019-2026

  • PDF Icon

    Report

  • 316 Pages
  • June 2020
  • Region: Global
  • Allied Market Research
  • ID: 5134071
The global vital signs monitoring devices market was valued at $4,655.9 million in 2018 and is projected to reach $7,813.5 million by 2026, registering a CAGR of 6.6% from 2019 to 2026. Vital signs monitoring devices are used for measurement of vital parameters, including blood pressure, heart rate, respiratory rate, & body temperature, and helps in monitoring physical functioning of the body. They offer clinically relevant information regarding the health status of patients. This information plays a vital role in identifying presence of any acute medical problem or chronic disease state. Vital signs of a patient are recorded at emergency departments, pre- and post-surgery, and during treatment at hospitals.





The global vital signs monitoring devices market is expected to witness a significant growth during the forecast period, owing to an increase in importance of vital signs monitoring devices in home care settings and improved reimbursement scenario in developed countries. In addition, surge in geriatric population and a rise in incidence rate of cardiovascular disorders such as hypertension and other preexisting health conditions including COPD, sleep apnea, and infectious diseases fuel the demand for vital signs monitoring devices, globally. Moreover, an increase in use of vital signs monitoring devices for fitness monitoring and a rise in ambulatory surgery centers across various countries, which use vital signs monitoring devices routinely, foster market growth. However, lack of awareness about these devices in low- and middle-income countries hamper market growth.

The vital signs monitoring devices market is segmented on the basis of product type, end user, and region. By product type, the market is divided into blood pressure monitoring devices, pulse oximeters, and temperature monitoring devices. Under the blood pressure monitoring devices, the market is further divided into aneroid BP Monitors, digital BP monitors, blood pressure instrument accessories and ambulatory BP monitors. Under the pulse oximeters segment, the market is further classified into table-top/bedside pulse oximeters, fingertip pulse oximeters, hand-held pulse oximeters, wrist-worn pulse oximeters and pediatric pulse oximeters. Under the temperature monitoring devices segment, the market is further segmented into mercury-filled thermometers, digital thermometers, infrared thermometers and temperature strips. By end user, the market is segregated into hospitals & clinics, ambulatory surgery centers, and home care settings. By region, it is studied across North America, Europe, Asia-Pacific, and LAMEA.

Prominent players have adopted product development, product launches, approvals, and clinical trials as their key developmental strategies for expanding their product portfolio. For instance, on November 5, 2019 Philips launched next-gen vital signs monitor “EarlyVue VS30” for early diagnosing and patient intervention. The device captures medical data from a patient and transmits it to hospital’s medical records, thereby enhancing patient treatment and reducing errors. Moreover, reimbursement policies for these devices fuel the demand for vital signs monitoring products. For instance, Medicare offers reimbursement for pulse oximeters used for a pulmonary disease(s) in case of using diagnosis code ICD-9-CM, which describes a patient’s condition and motive of using the service or procedure. The present procedural technology identifies three codes for oximetry, namely, 94760, 94761, and 94762.

KEY BENEFITS FOR STAKEHOLDERS
  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2026, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global laparoscopy devices market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

By Product Type
  • Blood Pressure Monitoring Device
  • Aneroid BP Monitors
  • Digital BP Monitors
  • Blood Pressure Instrument Accessories
  • Ambulatory BP Monitors
  • Pulse Oximeters
  • Table-top/Bedside Pulse Oximeters
  • Fingertip Pulse Oximeters
  • Hand-held Pulse Oximeters
  • Wrist-worn Pulse Oximeters
  • Pediatric Pulse Oximeters
  • Temperature Monitoring Device
  • Mercury-filled Thermometers
  • Digital Thermometers
  • Infrared Thermometers
  • Temperature Strips

By End User
  • Hospitals & Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Home Care Settings

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • Australia
  • Japan
  • India
  • China
  • Taiwan
  • Thailand
  • Indonesia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Turkey
  • Venezuela
  • Colombia
  • Saudi Arabia
  • South Africa
  • Argentina
  • Rest of LAMEA

Key Market Players
  • Hill-Rom Holdings, Inc.
  • Halma plc (SunTech Medical, Inc.)
  • Nonin Medical, Inc.
  • Omron Corporation
  • Masimo Corporation
  • General Electric Company
  • Medtronic plc
  • Nihon Kohden Corporation
  • Koninklijke Philips N.V.
  • A&D Company, Limited
  • Contec Medical System Co., Ltd
  • Smiths Group plc.
Frequently Asked Questions about the Global Vital Signs Monitoring Devices Market

What is the estimated value of the Global Vital Signs Monitoring Devices Market?

The Global Vital Signs Monitoring Devices Market was estimated to be valued at $4655.9 million in 2018.

What is the growth rate of the Global Vital Signs Monitoring Devices Market?

The growth rate of the Global Vital Signs Monitoring Devices Market is 6.7%, with an estimated value of $7813.5 million by 2026.

What is the forecasted size of the Global Vital Signs Monitoring Devices Market?

The Global Vital Signs Monitoring Devices Market is estimated to be worth $7813.5 million by 2026.

Who are the key companies in the Global Vital Signs Monitoring Devices Market?

Key companies in the Global Vital Signs Monitoring Devices Market include Hill, Rom Holdings Inc, Halma plc (SunTech Medical Inc., Nonin Medical Inc, Omron Corporation, Masimo Corporation, General Electric Company, Medtronic plc and Koninklijke Philips NV.

Table of Contents

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Key Findings of the Study
2.2. CXO Perspective
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porters Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power Among Buyers
3.4. Market Share Analysis
3.4.1. Market Share Analysis, 2018
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Increase in Geriatric Population
3.5.1.2. Technological Advancement in Vital Signs Monitoring Devices
3.5.1.3. Rise in Prevalence of Diseases
3.5.1.4. Rise in Demand for Portable Monitoring Devices
3.5.2. Restraint
3.5.2.1. Lack of Awareness in Developing Countries
3.5.3. Opportunity
3.5.3.1. Increase in Healthcare Expenditure in Emerging Economies
3.5.3.2. Proactive Monitoring
Chapter 4: Vital Signs Monitoring Devices Market, by Product Type
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Blood Pressure (Bp) Monitoring Devices
4.2.1. Key Market Trends and Opportunities
4.2.2. Market Size and Forecast, by Type
4.2.3. Market Analysis, by Country
4.2.4. Aneroid Bp Monitors
4.2.4.1. Market Size and Forecast
4.2.5. Digital Bp Monitor
4.2.5.1. Market Size and Forecast
4.2.6. Blood Pressure Instrument Accessories
4.2.6.1. Market Size and Forecast
4.2.7. Ambulatory Bp Monitors
4.2.7.1. Market Size and Forecast
4.3. Pulse Oximeters
4.3.1. Key Market Trends and Opportunities
4.3.2. Market Size and Forecast, by Type
4.3.3. Market Analysis, by Country
4.3.4. Tabletop Bedside Pulse Oximeters
4.3.4.1. Market Size and Forecast
4.3.5. Fingertip Pulse Oximeters
4.3.5.1. Market Size and Forecast
4.3.6. Wrist Worn Pulse Oximeters
4.3.6.1. Market Size and Forecast
4.3.7. Hand-Held
4.3.7.1. Market Size and Forecast
4.3.8. Pediatric Pulse Oximeters
4.3.8.1. Market Size and Forecast
4.4. Temperature Monitoring Devices
4.4.1. Key Market Trends and Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.3. Market Analysis, by Country
4.4.4. Mercury Filled Thermometers
4.4.4.1. Market Size and Forecast
4.4.5. Digital Thermometers
4.4.5.1. Market Size and Forecast
4.4.6. Infrared Thermometers
4.4.6.1. Market Size and Forecast
4.4.7. Temperature Strips
4.4.7.1. Market Size and Forecast
Chapter 5: Vital Signs Monitoring Devices Market, by End-user
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Hospitals & Clinics
5.2.1. Market Size and Forecast, by Region
5.2.2. Market Analysis, by Country
5.3. Ambulatory Surgery Centers
5.3.1. Market Size and Forecast, by Region
5.3.2. Market Analysis, by Country
5.4. Home Care Settings
5.4.1. Market Size and Forecast, by Region
5.4.2. Market Analysis, by Country
Chapter 6: Vital Signs Monitoring Devices Market, by Region
6.1. Overview
6.1.1. Market Size and Forecast
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, by Product
6.2.3. Market Size and Forecast, by End-user
6.2.4. Market Size and Forecast, by Country
6.2.4.1. U. S. Market Size and Forecast, by Product
6.2.4.2. U. S. Market Size and Forecast, by End-user
6.2.4.3. Canada Market Size and Forecast, by Product
6.2.4.4. Canada Market Size and Forecast, by End-user
6.2.4.5. Mexico Market Size and Forecast, by Product
6.2.4.6. Mexico Market Size and Forecast, by End-user
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, by Product
6.3.3. Market Size and Forecast, by End-user
6.3.4. Market Size and Forecast, by Country
6.3.4.1. Germany Market Size and Forecast, by Product
6.3.4.2. Germany Market Size and Forecast, by End-user
6.3.4.3. France Market Size and Forecast, by Product
6.3.4.4. France Market Size and Forecast, by End-user
6.3.4.5. UK Market Size and Forecast, by Product
6.3.4.6. UK Market Size and Forecast, by End-user
6.3.4.7. Italy Market Size and Forecast, by Product
6.3.4.8. Italy Market Size and Forecast, by End-user
6.3.4.9. Spain Market Size and Forecast, by Product
6.3.4.10. Spain Market Size and Forecast, by End-user
6.3.4.11. Russia Market Size and Forecast, by Product
6.3.4.12. Russia Market Size and Forecast, by End-user
6.3.4.13. Rest of Europe Market Size and Forecast, by Product
6.3.4.14. Rest of Europe Market Size and Forecast, by End-user
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, by Product
6.4.3. Market Size and Forecast, by End-user
6.4.4. Market Size and Forecast, by Country
6.4.4.1. Japan Market Size and Forecast, by Product
6.4.4.2. Japan Market Size and Forecast, by End-user
6.4.4.3. China Market Size and Forecast, by Product
6.4.4.4. China Market Size and Forecast, by End-user
6.4.4.5. Australia Market Size and Forecast, by Product
6.4.4.6. Australia Market Size and Forecast, by End-user
6.4.4.7. India Market Size and Forecast, by Product
6.4.4.8. India Market Size and Forecast, by End-user
6.4.4.9. South Korea Market Size and Forecast, by Product
6.4.4.10. South Korea Market Size and Forecast, by End-user
6.4.4.11. South Korea Market Size and Forecast, by End-user
6.4.4.12. Taiwan Market Size and Forecast, by Product
6.4.4.13. Taiwan Market Size and Forecast, by End-user
6.4.4.14. Indonesia Market Size and Forecast, by Product
6.4.4.15. Indonesia Market Size and Forecast, by End-user
6.4.4.16. Thailand Market Size and Forecast, by Product
6.4.4.17. Thailand Market Size and Forecast, by End-user
6.4.4.18. Rest of Asia-Pacific Market Size and Forecast, by Product
6.4.4.19. Rest of Asia-Pacific Market Size and Forecast, by End-user
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, by Product
6.5.3. Market Size and Forecast, by End-user
6.5.4. Market Size and Forecast, by Country
6.5.4.1. Brazil Market Size and Forecast, by Product
6.5.4.2. Brazil Market Size and Forecast, by End-user
6.5.4.3. Turkey Market Size and Forecast, by Product
6.5.4.4. Turkey Market Size and Forecast, by End-user
6.5.4.5. Venezuela Market Size and Forecast, by Product
6.5.4.6. Venezuela Market Size and Forecast, by End-user
6.5.4.7. Colombia Market Size and Forecast, by Product
6.5.4.8. Colombia Market Size and Forecast, by End-user
6.5.4.9. Saudi Market Size and Forecast, by Product
6.5.4.10. Saudi Market Size and Forecast, by End-user
6.5.4.11. South Africa Market Size and Forecast, by Product
6.5.4.12. South Africa Market Size and Forecast, by End-user
6.5.4.13. Argentina Market Size and Forecast, by Product
6.5.4.14. Argentina Market Size and Forecast, by End-user
6.5.4.15. Rest of LAMEA Market Size and Forecast, by Product
6.5.4.16. Rest of LAMEA Market Size and Forecast, by End-user
Chapter 7: Company Profiles
7.1. Hill-Rom Holdings, Inc.
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Business Performance
7.2. Halma plc
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.2.5. Business Performance
7.2.6. Key Strategic Moves and Developments
7.3. Nonin Medical, Inc
7.3.1. Company Overview
7.3.2. Operating Business Segments
7.3.3. Product Portfolio
7.4. Omron Corporation
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance
7.4.6. Key Strategic Moves and Developments
7.5. Masimo Corporation
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segment
7.5.4. Product Portfolio
7.5.5. Business Performance
7.5.6. Key Strategic Moves and Developments
7.6. General Electric Company
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Business Performance
7.7. Medtronic plc
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Product Portfolio
7.7.5. Business Performance
7.8. Nihon Kohden Corporation
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Product Portfolio
7.8.5. Business Performance
7.9. Koninklijke Philips N. V.
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.9.5. Business Performance
7.9.6. Key Strategic Moves and Developments
7.10. A&D Company, Limited
7.10.1. Company Overview
7.10.2. Operating Business Segments
7.10.3. Product Portfolio
7.10.4. Business Performance
7.10.5. Key Strategic Moves and Developments
7.11. Contec Medical System Co. Ltd.
7.11.1. Company Overview
7.11.2. Company Snapshot
7.11.3. Operating Business Segments
7.11.4. Product Portfolio
7.12. Smiths Group plc
7.12.1. Company Overview
7.12.2. Company Snapshot
7.12.3. Operating Business Segments
7.12.4. Product Portfolio
7.12.5. Business Performance

Companies Mentioned

  • Hill-Rom Holdings Inc
  • Halma plc (SunTech Medical Inc.
  • Nonin Medical Inc
  • Omron Corporation
  • Masimo Corporation
  • General Electric Company
  • Medtronic plc
  • Nihon Kohden Corporation
  • Koninklijke Philips NV
  • A&D Company
  • Limited Contec Medical System Co Ltd
  • Smiths Group plc

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...